1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
Global Cardiovascular Ultrasound Market By Display, By Technology, By Type, By End Use, By Regional Outlook, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

Global Cardiovascular Ultrasound Market By Display, By Technology, By Type, By End Use, By Regional Outlook, COVID-19 Impact Analysis Report and Forecast, 2021 - 2027

  • August 2021
  • 266 pages
  • ID: 6155843
  • Format: PDF
  • KBV Research

Summary

Table of Contents

The Global Cardiovascular Ultrasound Market size is expected to reach $2.6 billion by 2027, rising at a market growth of 10.4% CAGR during the forecast period. Cardiovascular ultrasound refers to a non-invasive medical procedure that is utilized to diagnose the functioning of the heart using high-frequency reflected sound. In the procedure, a transducer (like a microphone) is utilized to transfer ultrasound waves at a high inaudible frequency. At the time when the transducer is situated on the chest at particular locations and angles, the ultrasonic sound waves infiltrate through the skin and other body tissues to the heart tissues and get displayed by the heart structures. These sound waves are then eventually transferred to a computer, developing moving pictures of the heart walls and valves.

Factors such as technological developments, surging cardiovascular diseases (CVDs), and the benefits of echocardiography over invasive cardiac diagnostic procedures are acting as catalysts for the growth of the cardiovascular ultrasound market. Additionally, this technology is broadly adopted among the patients due to its non-invasive nature, thereby reduces the stay at hospitals. This factor further boosts the growth of the global cardiovascular ultrasound market. Though, the economic impact on adopting the latest technologies and inadequate reimbursement conditions is expected to hamper the growth of the global market. Technological developments resulting in cardiac-based technologies like tissue improvements, lateral gain control, sophisticated dynamic flow, stress echo, and tissue Doppler would offer lucrative growth opportunities for the players operating in the global cardiovascular ultrasound market during the forecast period.

COVID-19 Impact

The outbreak of the COVID-19 pandemic hindered the growth of the global cardiovascular ultrasound market because outpatient imaging services were negatively affected. Cardiovascular ultrasound (CVUS) is a crucial device to determine cardiovascular functions in COVID-19 patients since any conditions associated with the cardiac system increase the possibility of mortality. In addition, one of the major drivers of cardiovascular ultrasound has been the cardiac damage after the COVID-19 recovery.

As per the research by Mount Sinai Hospital of New York, around 66% of the COVID-19 recovered patients were witnessed to have a cardiac structural abnormality. In gauging the state of these patients, cardiovascular ultrasound plays a major role. This would fuel the demand for the latest and sophisticated CVUS systems during the forecasting period. Various countries across the world have varied reimbursement norms regarding various forms of ultrasounds.

Market Growth Factors:

Supportive norms are set to boost the market growth

There are various supportive norms regarding cardiovascular ultrasound formulated by numerous governments across the globe that would create new growth avenues for the global cardiovascular ultrasound market over the forecast years. Many insurance companies are including cardiovascular diseases in their insurance plan. Therefore, favorable reimbursement policies under the insurance plan about cardiovascular diseases are anticipated to fuel the growth of the global cardiovascular ultrasound market in the upcoming years.

High occurrence of cardiovascular diseases

The surge in the occurrence of cardiovascular diseases has boosted the demand & growth of the cardiovascular ultrasound market. Cardiovascular imaging ultrasound systems like echocardiography and sonograms are broadly installed for the diagnosis and monitoring of cardiovascular diseases such as coronary artery disease, congenital heart disease, peripheral artery disease, atherosclerosis, arrhythmia, and among others. The rise in the cases of cardiovascular disease is expected to fuel the demand for cardiovascular ultrasound systems in the upcoming years.

Market Restraining Factor:

High cost of cardiovascular ultrasound systems

Healthcare facilities with low-budget are unable to deploy cardiovascular ultrasound machines due to their high initial cost. This could act as a significant obstacle to the growth of the global cardiovascular ultrasound market. In addition, poverty levels in many under-developed, as well as developing countries, have reached to an undesirable level. People who fall below the poverty line and suffering from different kinds of cardiovascular diseases find it difficult to manage the cost of cardiovascular ultrasound, thereby hampering the further growth of the cardiovascular ultrasound market.

Display Outlook

Based on Display, the market is segmented into Color Display and B/W Display. The Color Display market dominated the Global Cardiovascular Ultrasound Market by Display 2020, growing at a CAGR of 11.2 % during the forecast period. The B/W Display market is expected to witness a CAGR of 5.2% during (2021 - 2027).

Technology Outlook

Based on Technology, the market is segmented into Doppler, 2D and 3D/4D. The 3D & 4D technology segment would showcase the highest growth rate during the forecast period. It is owing to the superior image resolution offered by this technology. 3D ultrasound imaging has the capability that can give real-time imaging of the anatomical structure. For guiding interventional procedures, real-time 3D ultrasound offers various kinds of benefits.

Type Outlook

Based on Type, the market is segmented into Transthoracic echocardiography, Transesophageal echocardiography, Fetal echocardiography and Others. The transthoracic echocardiography segment obtained the maximum revenue share of the cardiovascular ultrasound market in 2020. The fetal echocardiography segment would display the fastest growth rate during the forecasting period. A fetal echocardiogram is one of the crucial pregnancy tests, which is usually conducted in the second trimester to know whether all four chambers of the heart are made in the fetus.

End Use Outlook

Based on End Use, the market is segmented into Hospital, Diagnostic centers, Ambulatory care centers and Others. Many large-scale hospitals have their own medical imaging units. On the other hand, medical imaging facilities require timely maintenance and heavy initial cost, huge space, and efficient professionals. These aspects expand the financial pressure on hospitals in the management of such units. Therefore, hospitals are more inclined to form a partnership with diagnostic centers for medical imaging units. This facilitates cost-saving, particularly in small- and mid-sized hospitals.

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. The APAC would exhibit the fastest growth rate during the forecasting period. Factor such as the surge in the occurrence of chronic conditions in the region is responsible for the growth of this region.

The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; Samsung Electronics Co., Ltd. is the major forerunners in the Cardiovascular Ultrasound Market. Companies such as General Electric (GE) Co., Koninklijke Philips N.V., FUJIFILM Sonosite, Inc. are some of the key innovators in the market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Siemens AG (Siemens Healthineers), Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.), Mindray Medical International Limited, Chison Medical Technologies Co., Ltd., FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation), Canon, Inc. (Canon Medical Systems Corporation) and Esaote SpA.

Recent Strategies Deployed in Cardiovascular Ultrasound Market

Partnerships, Collaborations, and Agreements:

Mar-2021: Royal Philips came into partnership with DiA Imaging Analysis Ltd., a leading provider of AI-powered applications for an ultrasound. This partnership aimed to deliver automated solutions to clinicians at the point-of-care and support Philips’ mission to integrate AI partners into the Radiology workflow ecosystem, from the modality to interpretation.

Product Launches and Product Expansions:

May-2021: Esaote launched the new MyLab X9 ultrasound system. This system provides the top level of image quality and data processing capability, utilizing the new technological solutions to explore the latest frontiers of ultrasound imaging.

May-2021: Mindray unveiled its new Cardiology ultrasound solutions. These solutions consist of HiFR V-Flow, TEE imaging, real-time IMT, Wall Shear Stress (WSS). In addition, these technologies enable truly precise visualization that arms clinicians with more evidence for diagnostic certainty.

Mar-2021: GE Healthcare launched Venue Fit, a streamlined and compact point-of-care ultrasound (POCUS) system along with an industry-first AI portfolio for cardiac imaging on the Venue and Venue Go. This product is the smallest system in GE Healthcare’s Venue portfolio, which features intuitive scanning tools, an easy-to-clean touchscreen, and a small footprint developed to fit in small spaces mostly found in point-of-care settings.

Mar-2021: General Electric unveiled Vscan Air, its new wireless, hand-held ultrasound device. This device is utilized by trained healthcare providers to rapidly analyze blood flow, gallbladder disease and assess & supervise Covid-19 via a lung exam.

Oct-2020: Samsung Medison launched a new ultrasound system HERA W10 and prototype of a chair-type ultrasound system HERA I10. This system is a new premium platform that stands for Hyper-aperture Enhanced Reconstruction Architecture, including Samsung’s latest Crystal Architecture to deliver improved technology and offerings with a new level of image quality.

Sep-2020: GE Healthcare introduced Vivid Ultra Edition, a new cardiovascular ultrasound package based on artificial intelligence (AI). This launch showcased GE’s integration of AI into echocardiography scanning and is accessible across the whole vivid cardiovascular ultrasound portfolio.

Aug-2020: GE introduced new innovations to Vscan Extend system. These advances include the LVivo EF app from DiA Imaging Analysis for AI-based automated ejection fraction analysis. This AI app creates left ventricular (LV) ejection fraction (EF) fast and reproducible utilizing a hand-held point of care ultrasound system that can be operated by inexperienced sonographers too.

Aug-2020: Royal Philips introduced the new addition to its portfolio of dedicated cardiovascular ultrasound solutions, Affiniti CVx for boosted productivity. The system enhancements support cardiology departments in providing better care to more patients with enhanced efficiency and throughput.

Jul-2020: FUJIFILM Sonosite introduced a new Sonosite PX ultrasound system. This system is the new generation in Sonosite POCUS, with the improved image clarity ever seen in a Sonosite system, a portfolio of workflow efficiency features, and an adaptable form factor.

Jan-2020: Healthineers introduced the ACUSON Redwood Ultrasound System. The system is developed with the company’s latest platform architecture and includes improved applications for more clinical confidence, AI-powered tools for smart workflows, and shared services cardiology features utilized by various hospital departments.

Geographical Expansions:

Jul-2020: Royal Philips launched its Lumify with Reacts handheld tele-ultrasound solution in Japan. Philips ultrasound portfolio reinforces the efficient and effective delivery of care over a wide variety of clinical specialties that include cardiology, radiology, point-of-care, and obstetrics/gynecology.

Approvals and Trials:

Apr-2021: Canon Medical Systems USA got US FDA 510(k) clearance for its Deep Learning Spectral CT. Accessible on the company’s Aquilion ONE / PRISM Edition CT system, healthcare providers could get whole-heart spectral images in one beat due to the system’s 16 cm wide area detector, 0.275 second whole-heart acquisition with rapid kVp switching, and Deep Learning Spectral Reconstruction.

Oct-2020: GE Healthcare received the U.S. FDA 510k clearance for its Ultra Edition package on Vivid cardiovascular ultrasound systems. These systems offer the latest features based on artificial intelligence (AI), which helps clinicians to get faster, more repeatable exams constantly.

May-2020: Philips Healthcare got 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market a broad variety of its ultrasound solutions for the management of COVID-19 associated lung and cardiac complications. Following this clearance, Philips can offer detailed, practical guidance to assist clinicians in utilizing its systems & software for patients affected by COVID-19.

Scope of the Study

Market Segments covered in the Report:

By Display

• Color Display and

• B/W Display

By Technology

• Doppler

• 2D and

• 3D/4D

By Type

• Transthoracic echocardiography

• Transesophageal echocardiography

• Fetal echocardiography and

• Others

By End Use

• Hospital

• Diagnostic centers

• Ambulatory care centers and

• Others

By Geography

• North America

o US

o Canada

o Mexico

o Rest of North America

• Europe

o Germany

o UK

o France

o Russia

o Spain

o Italy

o Rest of Europe

• Asia Pacific

o China

o Japan

o India

o South Korea

o Singapore

o Malaysia

o Rest of Asia Pacific

• LAMEA

o Brazil

o Argentina

o UAE

o Saudi Arabia

o South Africa

o Nigeria

o Rest of LAMEA

Companies Profiled

• General Electric (GE) Co. (GE Healthcare)

• Koninklijke Philips N.V.

• Siemens AG (Siemens Healthineers)

• Samsung Electronics Co., Ltd. (Samsung Group) (Samsung Medison Co., Ltd.)

• Mindray Medical International Limited

• Chison Medical Technologies Co., Ltd.

• FUJIFILM Sonosite, Inc. (Fujifilm Holdings Corporation)

• Canon, Inc. (Canon Medical Systems Corporation)

• Esaote SpA

Unique Offerings

• Exhaustive coverage

• Highest number of market tables and figures

• Subscription based model available

• Guaranteed best price

• Assured post sales research support with 10% customization free

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Neurovascular Devices Market Research Report by Disease Pathology, by Devices, by End-User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • $ 4949
  • October 2021
  • 189 pages

Neurovascular Devices Market Research Report by Disease Pathology (Aneurysm, Arteriovenous Malformation and Fistulas (AVM), and Ischemic Stroke), by Devices (Cerebral Angioplasty and Stenting Systems, ...

  • World
  • Neurological Disorder
  • Pathology
  • Industry analysis

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on